This Week on NeurologyLive® — February 26, 2024
Here's some of what is coming soon to NeurologyLive® this week.
CGRP and Gepant Combination Safe, DNL788 Fails ALS Study, Frexalimab Promising Phase 2 Results in Relapsing MS
Neurology News Network for the week ending February 24, 2024. [WATCH TIME: 3 minutes]
NeurologyLive® Friday 5 — February 23, 2024
Take 5 minutes to catch up on NeurologyLive®'s highlights from the week ending February 23, 2024.
This Week on NeurologyLive® — February 19, 2024
Laquinimod Reduces Caudate Volume in Huntington, Assisted Reproductive Technologies Increase In-Hospital Stroke Risk, Omaveloxolone Approved in EU
Neurology News Network for the week ending February 17, 2024. [WATCH TIME: 3 minutes]
NeurologyLive® Friday 5 — February 16, 2024
Take 5 minutes to catch up on NeurologyLive®'s highlights from the week ending February 16, 2024.
This Week on NeurologyLive® — February 12, 2024
Adrenomedullin Safe in Ischemic Stroke, NfL and GFAP Levels Identified During Stroke, Fibrinogenase Improves Functional Outcomes
Neurology News Network for the week ending February 10, 2024. [WATCH TIME: 3 minutes]
NeurologyLive® Friday 5 — February 9, 2024
Take 5 minutes to catch up on NeurologyLive®'s highlights from the week ending February 9, 2024.
This Week on NeurologyLive® — February 5, 2024
Biogen Discontinues Aducanumab, CHMP Issues Negative Opinion on Ataluren, SRP-5051 Shines in MOMENTUM Study
Neurology News Network for the week ending February 3, 2024. [WATCH TIME: 3 minutes]
NeurologyLive® Friday 5 — February 2, 2024
Take 5 minutes to catch up on NeurologyLive®'s highlights from the week ending February 2, 2024.
This Week on NeurologyLive® — January 29, 2024
Cell Therapy HLCM051 Falls Short in Stroke Study, Benefits of Light Therapy in Alzheimer, IPL344 Phase 2a Data Released
Neurology News Network for the week ending January 27, 2024. [WATCH TIME: 3 minutes]
NeurologyLive® Friday 5 — January 26, 2024
Take 5 minutes to catch up on NeurologyLive®'s highlights from the week ending January 26, 2024.
This Week on NeurologyLive® — January 22, 2024
ALS Agent PrimeC Moves to Phase 3, FDA Clears IND for AB126, APOE Carrier Status Impacts ARIA
Neurology News Network for the week ending January 21, 2024. [WATCH TIME: 3 minutes]
NeurologyLive® Friday 5 — January 19, 2024
Take 5 minutes to catch up on NeurologyLive®'s highlights from the week ending January 19, 2024.
NeurologyLive® Friday 5 — January 12, 2024
Take 5 minutes to catch up on NeurologyLive®'s highlights from the week ending January 12, 2024.
ALS Agent CNM-Au8 Reduces NfL, Positive CLEAR-MIND Results, Decreased Learning Abilities in Narcolepsy
Neurology News Network for the week ending January 6, 2023. [WATCH TIME: 3 minutes]
This Week on NeurologyLive® — January 8, 2024
NeurologyLive® Friday 5 — January 5, 2024
Take 5 minutes to catch up on NeurologyLive®'s highlights from the week ending January 5, 2024.
NeurologyLive® Year in Review 2023: Most-Read Features
As part of NeurologyLive®'s Year in Review, we've compiled the most-read feature-length stories that appeared on the website in 2023.
NeurologyLive® Friday 5 — December 29, 2023
Take 5 minutes to catch up on NeurologyLive®'s highlights from the week ending December 29, 2023.
NeurologyLive® Year in Review 2023: Top Stories in Sleep Disorders
As part of NeurologyLive®'s Year in Review, take a look at the most-read news articles on our site in sleep disorders in 2023.
NeurologyLive® Year in Review 2023: Most Watched Interviews in Multiple Sclerosis
As part of NeurologyLive®'s Year in Review, take a look at our most-watched expert interviews in multiple sclerosis in 2023.
NeurologyLive® Year in Review 2023: Most Watched Interviews in Epilepsy and Seizure Disorders
As part of NeurologyLive®'s Year in Review, take a look at our most-watched interviews with key opinion leaders in epilepsy and seizure disorders in 2023.
NeurologyLive® Year in Review 2023: Top Stories in Neuromuscular Disorders
As part of NeurologyLive®'s Year in Review, take a look at our most-read news in neuromuscular disorders in 2023.
NeurologyLive® Year in Review 2023: Most-Watched Headache and Migraine Expert Interviews
These were the most-watched interviews with experts in headache and migraine that we conducted in 2023, brought to you as part of NeurologyLive®'s Year in Review.
NeurologyLive® Year in Review 2023: Top Stories in Multiple Sclerosis
As part of NeurologyLive®'s Year in Review, take a look at our most-read news in multiple sclerosis in 2023.